Activity Prediction and Structural Insights of Extracellular Signal-Regulated Kinase 2 Inhibitors with Molecular Dynamics Simulations

被引:14
作者
Del Rio, Alberto [1 ]
Baldi, Benedetta Frida [1 ]
Rastelli, Giulio [1 ]
机构
[1] Univ Modena & Reggio Emilia, Dipartimento Sci Farmaceut, I-41100 Modena, Italy
关键词
anticancer drugs; binding free energy; ERK2; MM-PBSA; molecular dynamics; protein kinases; LIGAND BINDING AFFINITIES; AUTOMATED PROCEDURE; INTERACTION MAP; FREE-ENERGIES; DRUG DESIGN; MM-PBSA; MUTATION; DOCKING; MODE; ERK;
D O I
10.1111/j.1747-0285.2009.00903.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A computational application to predict, probe and interpret the activities of a series of congeneric compounds inhibiting extracellular signal-regulated kinase 2 protein kinase is presented. The study shows that molecular dynamics coupled with molecular mechanics Poisson-Boltzmann solvent accessible surface area free energy estimation is a suitable tool for investigating the experimental binding activities of ligands to protein kinases. Computed and experimental binding activities were found to be significantly correlated. Moreover, the interpretation of the X-ray co-crystal structure in conjunction with computational results shows that the hinge region of the protein insure the principal binding site via multiple hydrogen bonding interactions, whereas fine-modulation of biological activities along the series is accomplished through the combination of weak and strong interactions that compete with water. These are located in the substituent moieties of the ligands interfacing with the DFG motif, the sugar region and the hydrophobic pocket of extracellular signal-regulated kinase 2. The study suggests that a wider interaction framework that is well beyond the hinge region is required to predict and rationalize at molecular level the experimental biological activities of congeneric compound series.
引用
收藏
页码:630 / 635
页数:6
相关论文
共 25 条
[1]   Flipped out: Structure-guided design of selective pyrazolylpyrrole ERK inhibitors [J].
Aronov, Alex M. ;
Baker, Christopher ;
Bemis, Guy W. ;
Cao, Jingrong ;
Chen, Guanjing ;
Ford, Pamella J. ;
Germann, Ursula A. ;
Green, Jeremy ;
Hale, Michael R. ;
Jacobs, Marc ;
Janetka, James W. ;
Maltais, Francois ;
Martinez-Botella, Gabriel ;
Namchuk, Mark N. ;
Straub, Judy ;
Tang, Qing ;
Xie, Xiaoling .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (06) :1280-1287
[2]   Kinase Domain Mutations in Cancer: Implications for Small Molecule Drug Design Strategies [J].
Bikker, Jack A. ;
Brooijmans, Natasja ;
Wissner, Allan ;
Mansour, Tarek S. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (06) :1493-1509
[3]   Chemical inhibitors of protein kinases [J].
Bridges, AJ .
CHEMICAL REVIEWS, 2001, 101 (08) :2541-2571
[4]   Rapid estimation of relative protein-ligand binding affinities using a high-throughput version of MM-PBSA [J].
Brown, Scott P. ;
Muchmore, Steven W. .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (04) :1493-1503
[5]   The Amber biomolecular simulation programs [J].
Case, DA ;
Cheatham, TE ;
Darden, T ;
Gohlke, H ;
Luo, R ;
Merz, KM ;
Onufriev, A ;
Simmerling, C ;
Wang, B ;
Woods, RJ .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2005, 26 (16) :1668-1688
[6]   A small molecule-kinase interaction map for clinical kinase inhibitors [J].
Fabian, MA ;
Biggs, WH ;
Treiber, DK ;
Atteridge, CE ;
Azimioara, MD ;
Benedetti, MG ;
Carter, TA ;
Ciceri, P ;
Edeen, PT ;
Floyd, M ;
Ford, JM ;
Galvin, M ;
Gerlach, JL ;
Grotzfeld, RM ;
Herrgard, S ;
Insko, DE ;
Insko, MA ;
Lai, AG ;
Lélias, JM ;
Mehta, SA ;
Milanov, ZV ;
Velasco, AM ;
Wodicka, LM ;
Patel, HK ;
Zarrinkar, PP ;
Lockhart, DJ .
NATURE BIOTECHNOLOGY, 2005, 23 (03) :329-336
[7]   A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases [J].
Fedorov, Oleg ;
Marsden, Brian ;
Pogacic, Vanda ;
Rellos, Peter ;
Mueller, Susanne ;
Bullock, Alex N. ;
Schwaller, Juerg ;
Sundstrom, Michael ;
Knapp, Stefan .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (51) :20523-20528
[8]   Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors [J].
Ferrari, Anna Maria ;
Degliesposti, Gianluca ;
Sgobba, Miriam ;
Rastelli, Giulio .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (24) :7865-7877
[9]   The second wave in kinase cancer drugs [J].
Garber, K .
NATURE BIOTECHNOLOGY, 2006, 24 (02) :127-130
[10]   Calculation of protein-ligand binding affinities [J].
Gilson, Michael K. ;
Zhou, Huan-Xiang .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2007, 36 :21-42